STATE STREET CORP - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 3 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$7,000
-36.4%
16,1000.0%0.00%
Q3 2016$11,000
-65.6%
16,1000.0%0.00%
Q2 2016$32,000
-17.9%
16,1000.0%0.00%
Q1 2016$39,00016,1000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2017
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders